Friday 6 November 2026
Export GEVO’s income statement to Excel — free account
Gevo, Inc.
GEVO Basic Materials Specialty Chemicals
Gevo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.6 million, up 849.3% from fiscal 2024.
- Revenue
- +7.11%
- EPS
- −7,600.0%
- Free cash flow
- −167.5%
- Total debt
- +20.0%
Quarter to June 2026, against a year earlier
1.39
0.17
+13.93%
Follow GEVO
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(9.27%) | (7.08%) | (7.37%) | (56.98%) | |
Piotroski F-Score |
4 | 5 | 6 | 4 | |
| (7.00%) | (5.19%) | (5.08%) | (35.69%) | ||
ROIC |
(4.69%) | (2.42%) | (0.58%) | (29.79%) | |
Return on Tangible Assets |
(11.05%) | (8.09%) | (7.56%) | (70.48%) | |
Average Days of Receivables |
23.37 | 19.08 | 20.37 | 24.61 | |
Free Cash Flow per Share |
(0.37) | (0.19) | (0.18) | (0.24) | |
Free Cash Flow |
(85.73) | (43.51) | (43.65) | (56.65) | |
Capital Expenditures |
(33.53) | (30.11) | (33.15) | (40.40) | |
| Other line items | |||||
Cash ROIC |
(12.16%) | (5.87%) | (6.29%) | (11.35%) | |
Accounts Receivable Turnover |
26.42 | 29.72 | 16.24 | 15.44 | |
Accounts Payable Turnover |
2.44 | 2.91 | 3.12 | 2.28 | |
Inventory Turnover |
5.85 | 7.23 | 4.44 | 4.83 | |
Average Days of Payables |
180.04 | 156.33 | 111.05 | 139.31 | |
Days of Inventory on Hand |
98.50 | 81.68 | 92.42 | 80.54 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
10.02% | 10.09% | 8.42% | 8.88% | |
Selling, General and Administrative Expense of Revenue |
36.36% | 31.88% | 32.30% | 32.92% | |
Share Based Compensation of Revenue |
7.24% | 5.73% | 5.40% | 5.48% | |
Interest Coverage |
(2.70) | (1.15) | (0.26) | (8.81) | |
Operating CF/Net income |
1.16 | 0.40 | 0.31 | 0.08 | |
Depreciation/Fixed assets |
0.08 | 0.08 | 0.09 | 0.13 | |
Capex/Depreciation |
(1.21) | (1.03) | (1.08) | (1.34) | |
Revenue per Share |
0.52 | 0.69 | 0.74 | 0.75 | |
Operating CF per Share |
(0.22) | (0.06) | (0.04) | (0.07) | |
Capex per Share |
(0.14) | (0.13) | (0.14) | (0.17) | |
Capex to Sales |
0.28 | 0.19 | 0.19 | 0.23 |
Columns are period end dates